Haematological and histopathological effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar female albino rats.
In this study, it is aimed to determine the histopathological and haematological effects of apigenin, phloretin and myricetin on Wistar immature female rats using Tier 2 of the uterotrophic assay. The female rats were divided into 17 groups with 6 rats in each group. There was a negative control group and positive control dose groups that contained 0.07 µg/kg/day, 0.7 µg/kg/day and 7 µg/kg/day of ethinyl estradiol (EE), 0.7 µg/kg/day 17α-ethinyl estradiol + 1 mg/kg/day tamoxifen and genistein. The other dose groups contain 1 mg/kg/day, 10 mg/kg/day and 100 mg/kg/day of apigenin, myricetin and phloretin. All chemicals had been given to Wistar immature female rats with oral gavage for three consecutive days. At the end of the study, blood samples were analysed for haematological parameters. Tissue samples that were taken from the liver, kidney, spleen and thyroid were histopathologically and histomorphometrically examined. There were no significant differences between oil control and other dose groups for glomerular histomorphometry. However, there were significant differences for thyroid histomorphometry. Especially, 10 and 100 mg/kg/day of phloretin dose groups had a significant increase in colloid surface area in thyroid compared with the 1 mg/kg/day of phloretin and oil control groups. Significant histopathological changes (congestion, degeneration, fibrosis and mononuclear cell infiltration) were noted in the tissue specimens obtained from the treatment groups compared with the control group. According to the results of the haematological analysis of the groups, especially the values of erythrocytes and haematocrit were increased significantly in most of the dose groups according to the oil control group.
Department of Biology, Faculty of Science, Hacettepe University, Beytepe Campus, Ankara, Turkey barlas@hacettepe.edu.tr.
N
N
Barlas
Department of Biology, Faculty of Science, Hacettepe University, Beytepe Campus, Ankara, Turkey.
G
G
Karabulut
D000818:Animals; D047310:Apigenin / Q000633:toxicity*; D001681:Biological Assay; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D005419:Flavonoids / Q000633:toxicity*; D006400:Hematocrit; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D010693:Phloretin / Q000633:toxicity*; D017208:Rats, Wistar; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D013961:Thyroid Gland / Q000187:drug effects / Q000473:pathology; D014599:Uterus / Q000187:drug effects / Q000254:growth & development
D005419:Flavonoids; C040015:myricetin; D047310:Apigenin; D010693:Phloretin
Apigenin; histopathology; myricetin; phloretin; phytoestrogen; rat